Literature DB >> 7530684

The expression of CD59 in normal human nervous tissue.

C Vedeler1, E Ulvestad, L Bjørge, G Conti, K Williams, S Mørk, R Matre.   

Abstract

The expression of CD59, a complement regulator of the formation and function of the terminal cytolytic membrane attack complex, was studied in human normal nervous tissue by immunohistochemical markers using two monoclonal antibodies 1F5 and MEM43. CD59 was present on Schwann cells, neurons and endothelial cells in the peripheral nervous system (PNS), and on Schwann cells in culture. In the central nervous system (CNS) CD59 was found predominantly on endothelial cells. There was also a diffuse staining of white and grey matter of the spinal cord and brain, presumably of microglia, oligodendrocytes, astrocytes and neurons, as these cells were CD59 positive in culture. Furthermore, CD59 was detected in the cerebrospinal fluid (CSF) of healthy individuals. CD59 in the PNS and CNS was glycosyl-phosphatidylinositol linked and had a molecular weight of 19,000-25,000. The presence of CD59 on various cells of the nervous system and in the CSF suggests that regulation of complement activation by this protein is important in neural host defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530684      PMCID: PMC1414919     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Soluble CD59 in pregnancy and infancy.

Authors:  L Bjørge; T S Jensen; C A Vedeler; E Ulvestad; E K Kristoffersen; R Matre
Journal:  Immunol Lett       Date:  1993-05       Impact factor: 3.685

2.  Activation of the alternative pathway of complement by human peripheral nerve myelin.

Authors:  C L Koski; P Vanguri; M L Shin
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Complement receptors CR1 on human peripheral nerve fibres.

Authors:  C A Vedeler; R Matre
Journal:  J Neuroimmunol       Date:  1988-03       Impact factor: 3.478

5.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

6.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

Authors:  C L Koski; M E Sanders; P T Swoveland; T J Lawley; M L Shin; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

8.  Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.

Authors:  S Schönermark; E W Rauterberg; M L Shin; S Löke; D Roelcke; G M Hänsch
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

9.  Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.

Authors:  M E Sanders; C L Koski; D Robbins; M L Shin; M M Frank; K A Joiner
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

Authors:  S K Singhrao; J W Neal; N K Rushmere; B P Morgan; P Gasque
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

3.  Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.

Authors:  S Meri; T Lehto; C W Sutton; J Tyynelä; M Baumann
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

4.  Expression and function of membrane regulators of complement on rat astrocytes in culture.

Authors:  C A Rogers; P Gasque; S J Piddlesden; N Okada; V M Holers; B P Morgan
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

5.  GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.

Authors:  K D Whitney; J O McNamara
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

6.  Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.

Authors:  P Gasque; B P Morgan
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

7.  Histopathology and high-resolution ultrasound imaging for peripheral nerve (injuries).

Authors:  Vincenzo Ricci; Costantino Ricci; Giulio Cocco; Fabrizio Gervasoni; Danilo Donati; Giacomo Farì; Levent Özçakar
Journal:  J Neurol       Date:  2022-01-29       Impact factor: 4.849

8.  Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.

Authors:  A Mäenpää; S Junnikkala; J Hakulinen; T Timonen; S Meri
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

9.  The complement cascade at the Utah microelectrode-tissue interface.

Authors:  Cassie Bennett; Anabel Álvarez-Ciara; Melissa Franklin; W Dalton Dietrich; Abhishek Prasad
Journal:  Biomaterials       Date:  2020-12-07       Impact factor: 12.479

10.  Implication of complement system and its regulators in Alzheimer's disease.

Authors:  Martin V Kolev; Marieta M Ruseva; Claire L Harris; B Paul Morgan; Rossen M Donev
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.